Literature DB >> 11779867

Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.

Juraj Bies1, Ján Markus, Linda Wolff.   

Abstract

The transcription factor c-Myb is subject to several types of post-translational modifications, including phosphorylation, acetylation, and ubiquitination. These modifications regulate the transcription and transforming activity as well as the proteolytic stability of c-Myb. Here we report the covalent modification of c-Myb with the small ubiquitin-related protein SUMO-1. Mutational analysis identified two major sumolation sites (Lys(499) and Lys(523)) in the negative regulatory domain. Interestingly, the single mutation K523R completely abolished modification of c-Myb with SUMO-1, suggesting that sumolation of Lys(523) is required for modification of other lysines in c-Myb. In accordance with this observation, we found that the SUMO-1-conjugating enzyme Ubc9 interacted only with a region surrounding Lys(523) (also called the PEST/EVES motif). Experiments aimed at determining the proteolytic stability of sumolated and unmodified forms of c-Myb revealed that at least two covalently attached SUMO-1 molecules dramatically increased the stability of c-Myb. However, mutations of the SUMO-1 modification sites did not alter its stability, suggesting that a mechanism(s) other than competition of ubiquitin and SUMO-1 for the same lysine is involved in the stabilization of sumolated c-Myb protein. Finally, the K523R mutant of c-Myb, entirely deficient in sumolation, was shown to have an increased transactivation capacity on a Myb-responsive promoter, suggesting that SUMO-1 negatively regulates the transactivation function of c-Myb. Thus, modification of c-Myb with SUMO-1 represents a novel mechanism through which the negative regulatory domain can exert its suppressing activity on c-Myb transactivation capacity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779867     DOI: 10.1074/jbc.M110453200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Modification with SUMO. A role in transcriptional regulation.

Authors:  Alexis Verger; José Perdomo; Merlin Crossley
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

2.  UBC9 autosumoylation negatively regulates sumoylation of septins in Saccharomyces cerevisiae.

Authors:  Chia-Wen Ho; Hung-Ta Chen; Jaulang Hwang
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

4.  SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.

Authors:  Michael Nevels; Wolfram Brune; Thomas Shenk
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties.

Authors:  Sergey Chupreta; Sam Holmstrom; Lalitha Subramanian; Jorge A Iñiguez-Lluhí
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.

Authors:  Yutaka Morita; Chie Kanei-Ishii; Teruaki Nomura; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

7.  PDSM, a motif for phosphorylation-dependent SUMO modification.

Authors:  Ville Hietakangas; Julius Anckar; Henri A Blomster; Mitsuaki Fujimoto; Jorma J Palvimo; Akira Nakai; Lea Sistonen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

8.  Negative modulation of androgen receptor transcriptional activity by Daxx.

Authors:  Ding-Yen Lin; Hsin-I Fang; Ai-Hong Ma; Yen-Sung Huang; Yeong-Shiau Pu; Guido Jenster; Hsing-Jien Kung; Hsiu-Ming Shih
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Blood pressure homeostasis is maintained by a P311-TGF-β axis.

Authors:  Kameswara Rao Badri; Ming Yue; Oscar A Carretero; Sree Latha Aramgam; Jun Cao; Stephen Sharkady; Gene H Kim; Gregory A Taylor; Kenneth L Byron; Lucia Schuger
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

10.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.